Keywords: tap, sub-licenses, cephalon, tech, entered, into, agreement

TAP SUB-LICENSES CEPHALON TECH

Article | 06 June 1994

Cephalon has entered into an agreement with Takeda-Abbott Pharmaceuticals of the USA regarding its receptor tyrosine kinase effector program. TAP ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Cephalon

Abbott

Abbott Laboratories

Kyowa Hakko

Go to company listing

Related Drugs

Leuprolide Acetate Injection

Lupron

Go to drug listing